ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

DYN Dyne Therapeutics Inc

35.07
-0.31 (-0.88%)
Last Updated: 23:36:31
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Dyne Therapeutics Inc DYN NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.31 -0.88% 35.07 23:36:31
Open Price Low Price High Price Close Price Previous Close
35.663 35.07 35.98 35.38
more quote information »

Recent News

Date Time Source Heading
21/5/202408:00EDGAR2Form 144 - Report of proposed sale of securities
21/5/202406:24EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
21/5/202406:01GLOBEDyne Therapeutics Announces Proposed Public Offering of..
20/5/202421:37EDGAR2Form 8-K - Current report
20/5/202420:30GLOBEDyne Therapeutics Announces New Clinical Data from ACHIEVE..
19/5/202422:00GLOBEDyne Therapeutics to Host Virtual Investor Event to Review..
18/5/202411:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/5/202411:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/5/202411:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/5/202406:26EDGAR2Form 144 - Report of proposed sale of securities
17/5/202406:23EDGAR2Form 144 - Report of proposed sale of securities
17/5/202406:18EDGAR2Form 144 - Report of proposed sale of securities
03/5/202406:10GLOBEDyne Therapeutics Reports First Quarter 2024 Financial..
28/3/202407:05GLOBEDyne Therapeutics Reports Inducement Grant Under Nasdaq..
27/3/202423:30GLOBEDyne Therapeutics to Present at the Cantor Virtual Muscular..
25/3/202422:30GLOBEDyne Therapeutics Announces CEO Transition
13/3/202422:30GLOBEDyne Therapeutics to Present at Stifel 2024 Virtual CNS Days
12/3/202408:36EDGAR2Form 144 - Report of proposed sale of securities
12/3/202408:35EDGAR2Form 144 - Report of proposed sale of securities
12/3/202408:35EDGAR2Form 144 - Report of proposed sale of securities
09/3/202408:53EDGAR2Form 144 - Report of proposed sale of securities
08/3/202412:19EDGAR2Form 144 - Report of proposed sale of securities
08/3/202412:18EDGAR2Form 144 - Report of proposed sale of securities
08/3/202412:16EDGAR2Form 144 - Report of proposed sale of securities
06/3/202400:22EDGAR2Form S-3ASR - Automatic shelf registration statement of..
05/3/202423:41EDGAR2Form 8-K - Current report
05/3/202423:40EDGAR2Form S-8 - Securities to be offered to employees in employee..
05/3/202423:35EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
05/3/202423:30GLOBEDyne Therapeutics Reports Fourth Quarter and Full Year 2023..
02/3/202413:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/3/202413:33EDGAR2Form 144 - Report of proposed sale of securities
02/3/202409:08EDGAR2Form 144 - Report of proposed sale of securities
01/3/202411:49EDGAR2Form 144 - Report of proposed sale of securities
24/2/202409:23EDGAR2Form 144 - Report of proposed sale of securities
15/2/202408:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202408:15GLOBEDyne Therapeutics Announces Upcoming Presentations on..
15/2/202400:39EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202409:40EDGAR2Form 144 - Report of proposed sale of securities
01/2/202423:30GLOBEDyne Therapeutics to Present at February Investor..
27/1/202411:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/1/202411:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/1/202411:46EDGAR2Form 144 - Report of proposed sale of securities
12/1/202408:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/1/202408:05GLOBEDyne Therapeutics Announces Closing of Public Offering of..
06/1/202408:07EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
06/1/202400:02EDGAR2Form 8-K - Current report
05/1/202423:30GLOBEDyne Therapeutics to Present at 42nd Annual J.P. Morgan..
05/1/202414:46GLOBEDyne Therapeutics Announces Pricing of $300 Million Public..
05/1/202413:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202413:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Your Recent History

Delayed Upgrade Clock